Academic Journal
P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL
| العنوان: | P1138: COPANLISIB + RITUXIMAB VS RITUXIMAB + PLACEBO IN PATIENTS WITH RELAPSED INDOLENT NON-HODGKIN LYMPHOMA (NHL): UPDATED SAFETY AND EFFICACY FROM THE PHASE III CHRONOS-3 TRIAL |
|---|---|
| المؤلفون: | P. L. Zinzani, M. Özcan, K. Sapunarova, W. Jurczak, A. Hamed, K. Bouabdallah, G. Saydam, K. Geissler, Á. Szomor, M. Lazaroiu, A. Salar, A. Tempescul, M. Nalcaci, L. Gercheva, M. Egyed, P. Panayiotidis, L. Mongay Soler, A. Cao, C. Phelps, B. H Childs, M. J Matasar |
| المصدر: | HemaSphere, Vol 6, Pp 1028-1029 (2022) |
| بيانات النشر: | Wiley |
| سنة النشر: | 2022 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Diseases of the blood and blood-forming organs, RC633-647.5 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 2572-9241 |
| Relation: | http://journals.lww.com/10.1097/01.HS9.0000847420.24995.43; https://doaj.org/toc/2572-9241; https://doaj.org/article/04696449ff50426f8b6ec43cb62e0dee |
| DOI: | 10.1097/01.HS9.0000847420.24995.43 |
| الاتاحة: | https://doi.org/10.1097/01.HS9.0000847420.24995.43 https://doaj.org/article/04696449ff50426f8b6ec43cb62e0dee |
| رقم الانضمام: | edsbas.9086F293 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 25729241 |
|---|---|
| DOI: | 10.1097/01.HS9.0000847420.24995.43 |